378 related articles for article (PubMed ID: 26383167)
1. The MYC-WDR5 Nexus and Cancer.
Thomas LR; Foshage AM; Weissmiller AM; Tansey WP
Cancer Res; 2015 Oct; 75(19):4012-5. PubMed ID: 26383167
[TBL] [Abstract][Full Text] [Related]
2. Mnt takes control as key regulator of the myc/max/mxd network.
Wahlström T; Henriksson M
Adv Cancer Res; 2007; 97():61-80. PubMed ID: 17419941
[TBL] [Abstract][Full Text] [Related]
3. WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma.
Sun Y; Bell JL; Carter D; Gherardi S; Poulos RC; Milazzo G; Wong JW; Al-Awar R; Tee AE; Liu PY; Liu B; Atmadibrata B; Wong M; Trahair T; Zhao Q; Shohet JM; Haupt Y; Schulte JH; Brown PJ; Arrowsmith CH; Vedadi M; MacKenzie KL; Hüttelmaier S; Perini G; Marshall GM; Braithwaite A; Liu T
Cancer Res; 2015 Dec; 75(23):5143-54. PubMed ID: 26471359
[TBL] [Abstract][Full Text] [Related]
4. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.
Li Z; Van Calcar S; Qu C; Cavenee WK; Zhang MQ; Ren B
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8164-9. PubMed ID: 12808131
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
6. The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth.
Pelengaris S; Khan M
Expert Opin Ther Targets; 2003 Oct; 7(5):623-42. PubMed ID: 14498825
[TBL] [Abstract][Full Text] [Related]
7. JQ1, an inhibitor of the epigenetic reader BRD4, suppresses the bidirectional MYC-AP4 axis via multiple mechanisms.
Choi SK; Hong SH; Kim HS; Shin CY; Nam SW; Choi WS; Han JW; You JS
Oncol Rep; 2016 Feb; 35(2):1186-94. PubMed ID: 26573731
[TBL] [Abstract][Full Text] [Related]
8. Repression by the Mad(Mxi1)-Sin3 complex.
Schreiber-Agus N; DePinho RA
Bioessays; 1998 Oct; 20(10):808-18. PubMed ID: 9819568
[TBL] [Abstract][Full Text] [Related]
9. The function and regulation of the JARID1 family of histone H3 lysine 4 demethylases: the Myc connection.
Secombe J; Eisenman RN
Cell Cycle; 2007 Jun; 6(11):1324-8. PubMed ID: 17568193
[TBL] [Abstract][Full Text] [Related]
10. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
Lüscher B; Larsson LG
Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
[TBL] [Abstract][Full Text] [Related]
11. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.
Grandori C; Mac J; Siëbelt F; Ayer DE; Eisenman RN
EMBO J; 1996 Aug; 15(16):4344-57. PubMed ID: 8861962
[TBL] [Abstract][Full Text] [Related]
12. Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC.
Thomas LR; Wang Q; Grieb BC; Phan J; Foshage AM; Sun Q; Olejniczak ET; Clark T; Dey S; Lorey S; Alicie B; Howard GC; Cawthon B; Ess KC; Eischen CM; Zhao Z; Fesik SW; Tansey WP
Mol Cell; 2015 May; 58(3):440-52. PubMed ID: 25818646
[TBL] [Abstract][Full Text] [Related]
13. In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation.
Perini G; Diolaiti D; Porro A; Della Valle G
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12117-22. PubMed ID: 16093321
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.
Reddy CD; Dasgupta P; Saikumar P; Dudek H; Rauscher FJ; Reddy EP
Oncogene; 1992 Oct; 7(10):2085-92. PubMed ID: 1408152
[TBL] [Abstract][Full Text] [Related]
15. Design and properties of a Myc derivative that efficiently homodimerizes.
Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
[TBL] [Abstract][Full Text] [Related]
16. Methods for the expression, purification, preparation, and biophysical characterization of constructs of the c-Myc and Max b-HLH-LZs.
Beaulieu ME; McDuff FO; Bédard M; Montagne M; Lavigne P
Methods Mol Biol; 2013; 1012():7-20. PubMed ID: 24006055
[TBL] [Abstract][Full Text] [Related]
17. Proteomic discovery of Max as a novel interacting partner of C/EBPalpha: a Myc/Max/Mad link.
Zada AA; Pulikkan JA; Bararia D; Geletu M; Trivedi AK; Balkhi MY; Hiddemann WD; Tenen DG; Behre HM; Behre G
Leukemia; 2006 Dec; 20(12):2137-46. PubMed ID: 17082780
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
19. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.
Vervoorts J; Lüscher B
Biol Chem; 1999 Sep; 380(9):1121-6. PubMed ID: 10543451
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule modulators of c-Myc/Max and Max/Max interactions.
Berg T
Curr Top Microbiol Immunol; 2011; 348():139-49. PubMed ID: 20680803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
